PONATINIB AND CHEMOTHERAPY IN YOUNG ADULTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA WITH PHILADELPHIC CHROMOSOME (LAL PH plus ). RESULTS OF THE PONALFIL CLINICAL TRIAL WITH MEDIUM 2-YEAR FOLLOW-UP
Por:
Santasusana, JMR, Garcia-Calduch, O, Martinez, P, Montesinos, P, Esteve, J, Torrent, A, Esteban, D, Garcia-Fortes, M, Alonso, N, Ribera, J, Gonzalez-Campos, J, Bermudez, A, Mercadal, S, Martinez-Lopez, J and Garcia-Sanz, R
Publicada:
1 oct 2021
Resumen:
Filiaciones:
:
ICO Hosp Germans Trias & Pujol, Inst Recerca Leucemia Josep Carreras IJC, Badalona, Spain
Garcia-Calduch, O:
ICO Hosp Germans Trias & Pujol, Inst Recerca Leucemia Josep Carreras IJC, Badalona, Spain
Martinez, P:
Hosp 12 Octubre Madrid, Madrid, Spain
Montesinos, P:
Hosp Univ La Fe Valencia, Valencia, Spain
Esteve, J:
Hosp Clin Barcelona, Barcelona, Spain
:
ICO Hosp Germans Trias & Pujol, Inst Recerca Leucemia Josep Carreras IJC, Badalona, Spain
Esteban, D:
Hosp Clin Barcelona, Barcelona, Spain
Garcia-Fortes, M:
Hosp Virgen Victoria Malaga, Malaga, Spain
Alonso, N:
Complejo Hosp Univ Santiago de Compostela, Santiago De Compostela, Spain
Gonzalez-Campos, J:
Hosp Virgen Rocio Sevilla, Seville, Spain
Bermudez, A:
Hosp Univ Marques Valdecilla Santander, Santander, Spain
Mercadal, S:
ICO Duran Reynals, Bellvitge, Spain
Martinez-Lopez, J:
Hosp 12 Octubre Madrid, Madrid, Spain
Garcia-Sanz, R:
Hosp Univ Salamanca, Salamanca, Spain
|